The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Por um escritor misterioso

Descrição

IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Figure 5 from Cardiorenal Syndrome Revisited
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
JCM, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
New insights into the pathophysiological mechanisms underlying
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Frontiers Insights of Worsening Renal Function in Type 1
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Renal fibrosis in type 2 cardiorenal syndrome: An update on
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Type 4 cardiorenal syndrome Revista Portuguesa de Cardiologia
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome prof.osama el-shahat
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Frontiers Cardiovascular-renal protective effect and molecular
de por adulto (o preço varia de acordo com o tamanho do grupo)